Model Number ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS |
Device Problem
Insufficient Information (3190)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 09/09/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer.The customer has informed hsc that this may be a sample specific issue, and that here have been no other discordants for the creatinine_2 assay on the advia chemistry system.The cause of the falsely elevated patient samples is unknown.
|
|
Event Description
|
The customer has obtained a falsely high result for the creatinine_2 assay on one patient sample on an advia chemistry 2400 instrument.The sample was run initially on (b)(6) 2016.A new sample draw was then run on an alternate platform and the result was lower.Another new sample draw was repeated on the same advia chemistry instrument on (b)(6) 2016 and the result was still higher than expected.The customer then decided to dilute the patient sample at 3 different dilution and the result was lower.The initial result was reported to the physician(s) and questioned.The result obtained on the alternate platform was also reported to the physician(s).There were no reports of patient intervention or adverse health consequences due to the high result on the patient sample for creatinine.
|
|
Manufacturer Narrative
|
Corrected information (10/26/2016): the reagent lot number for ecrea_2 and the udi number was listed incorrectly.This report has corrected information.In addition siemens headquarters support center (hsc) received feedback from a siemens customer service engineer (cse) at the site, regarding the ecrea_2 assay, whereas the use of the crea_2 jaffe assay may be more representative for the patient sample being tested.Siemens hsc has recommended based on this information provided by the cse that the customer use the crea_2 jaffe method, as there appears to be something in the patient sample interfering with the ecrea_2 result.The cause of the falsely elevated result on the patient sample is a possible interferant.
|
|
Manufacturer Narrative
|
The initial mdr 2432235-2016-00624 was filed on 10/18/2016.A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer.The customer has informed hsc that this may be a sample specific issue, and that here have been no other discordants for the enzymatic creatinine_2 assay on the advia chemistry system.Additional information (10/20/2016): upon further review of the complaint it was noted by a siemens designated complaint handling (dcu) representative that the correct assay was enzymatic creatinine_2 and not creatinine_2.Based on this information, the following sections were updated to reflect the correction.
|
|
Event Description
|
The customer has obtained a falsely high result for the enzymatic creatinine_2 ( ecrea_2) assay on one patient sample on an advia chemistry 2400 instrument.The sample was run initially on (b)(6) 2016.A new sample draw was then run on an alternate platform and the result was lower.Another new sample draw was repeated on the same advia chemistry instrument on (b)(6) 2016 and the result was still higher than expected.The customer then decided to dilute the patient sample at 3 different dilution and the result was lower.The initial result was reported to the physician(s) and questioned.The result obtained on the alternate platform was also reported to the physician(s).There were no reports of patient intervention or adverse health consequences due to the high result on the patient sample for enzymatic creatinine_2.
|
|
Search Alerts/Recalls
|